BioInvent Q3 2022 - financial position strengthened, projects progressing
2022-10-28 07:59:00
Redeye comments on BioInvents report for the third quarter, which saw a further strengthening of the financial position and progress in the clinical development programs.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.